In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer. - Feng X; Yang C; Huang Y; Su D; Wang C; Wilson LL; Yin L; Tang M; Li S; Chen Z; Zhu D; Wang S; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2024)